These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34885230)

  • 1. Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group.
    Petrova E; Wellner J; Nording AK; Braun R; Honselmann KC; Bolm L; Hummel R; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Timme-Bronsert S; Bronsert P; Zemskov S; Keck T; Wellner UF
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics of Resected Acinar Cell Carcinoma of the Pancreas: A Korean Multi-Institutional Study.
    Shin SH; Hwang HK; Jang JY; Kim H; Park SJ; Han SS; Han IW; Hwang DW; Heo JS
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group.
    Braun R; Klinkhammer-Schalke M; Zeissig SR; Kleihus van Tol K; Bolm L; Honselmann KC; Petrova E; Lapshyn H; Deichmann S; Abdalla TSA; Heckelmann B; Bronsert P; Zemskov S; Hummel R; Keck T; Wellner UF
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
    Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
    Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis.
    Xu Y; Zhang Y; Han S; Jin D; Xu X; Kuang T; Wu W; Wang D; Lou W
    Front Oncol; 2022; 12():789351. PubMed ID: 35433408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report.
    Ohara Y; Oda T; Enomoto T; Hisakura K; Akashi Y; Ogawa K; Owada Y; Domoto Y; Miyazaki Y; Shimomura O; Kurata M; Ohkohchi N
    World J Surg Oncol; 2018 Aug; 16(1):158. PubMed ID: 30075727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Survival after Resection of Pancreatic Cancer with and without Pancreatic Cysts: Nationwide Registry-Based Study.
    Gorris M; van Huijgevoort NCM; Farina A; Brosens LAA; van Santvoort HC; Groot Koerkamp B; Bruno MJ; Besselink MG; van Hooft JE;
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
    Gupta M; Sherrow C; Krone ME; Blais EM; Pishvaian MJ; Petricoin EF; Matrisian LM; DeArbeloa P; Gregory G; Brown A; Zalewski O; Prinzing G; Roche C; Kanehira K; Mukherjee S; Iyer R; Fountzilas C
    J Natl Compr Canc Netw; 2021 Jan; 19(1):10-15. PubMed ID: 33406492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Referral and treatment patterns in pancreatic acinar cell carcinoma: A regional population-level analysis.
    Patel RK; Parappilly M; Sutton TL; Behrens S; Schwantes IR; Johnson AJ; Pommier RF; Sheppard BC
    Am J Surg; 2024 May; 231():55-59. PubMed ID: 37087362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
    Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
    BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
    Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
    Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
    Skorupan N; Ghabra S; Maldonado JA; Zhang Y; Alewine C
    J Cancer Metastasis Treat; 2023; 9():. PubMed ID: 37538977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
    Zhang LP; Ren H; Du YX; Wang CF
    World J Gastroenterol; 2020 Dec; 26(46):7382-7404. PubMed ID: 33362391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries.
    Li Z; Zhang X; Sun C; Li Z; Fei H; Zhao D
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis.
    Klatte DCF; Boekestijn B; Onnekink AM; Dekker FW; van der Geest LG; Wasser MNJM; Feshtali S; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME;
    Gastroenterology; 2023 Jun; 164(7):1223-1231.e4. PubMed ID: 36889551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
    Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
    Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival after systemic chemotherapy, chemoradiotherapy, and maintenance therapy for an older adult patient with recurrent pancreatic acinar cell carcinoma.
    Urabe M; Ikezawa K; Kozumi K; Kai Y; Takada R; Mukai K; Nakabori T; Uehara H; Akita H; Ohkawa K
    Clin J Gastroenterol; 2024 Aug; 17(4):771-775. PubMed ID: 38743170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.